Prevalencia y carga de la coinfección del VHC en personas que viven con el VIH: revisión sistemática y metaanálisis globales

Publicaciones

Prevalencia y carga de la coinfección del VHC en personas que viven con el VIH: revisión sistemática y metaanálisis globales

29 febrero 2016
Peter Vickerman

Este estudio destaca la importancia de las pruebas rutinarias para la detección del VHC entre todas las personas con VIH, y en especial entre las personas que se inyectan drogas. Más información, en inglés, está disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

At global level, there are 37 million people infected with HIV and 115 million people with antibodies to hepatitis C virus (HCV). Little is known about the extent of HIV–HCV co-infection. We sought to characterise the epidemiology and burden of HCV co-infection in people living with HIV.

In this systematic review and meta-analysis we searched for studies measuring prevalence of HCV and HIV, published between Jan 1, 2002, and Jan 28, 2015. We included studies in HIV population samples of more than 50 individuals and recruited patients based on HIV infection status or other behavioural characteristics. We excluded editorials or reviews containing no primary data, samples of HCV or HIV–HCV co-infected individuals, or samples relying on self-reported infection status. We also excluded samples drawn from populations with other comorbidities or undergoing interventions that put them at increased risk of co-infection. Populations were categorised according to HIV exposure, with the regional burden of co-infection being derived by applying co-infection prevalence estimates to published numbers of HIV-infected individuals. We did a meta-analysis to estimate the odds of HCV in HIV-infected individuals compared with their HIV-negative counterparts.

Dr Lucy Platt, PhD; Philippa Easterbrook, MD; Erin Gower, MPH; Bethan McDonald, PhD; Keith Sabin, PhD; Catherine McGowan, PhD; Irini Yanny, MBChB; Homie Razavi, PhD; Prof Peter Vickerman, D Phil

Click here to read the article (restricted access to the report).

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: Pixabay

Regiones

Perfiles relacionados

  • World Health Organization (WHO)

Traducciones